What is the prevalence of Juvenile polyposis syndrome?

Juvenile polyposis syndrome (JPS) is a rare autosomal dominant condition with an estimated prevalence ranging from 1 in 16,000 to 1 in 100,000 individuals worldwide. Because many cases remain asymptomatic or are misdiagnosed, these figures are considered estimates, and the true incidence of Juvenile polyposis syndrome is likely higher than reported clinical data suggests.

How common is Juvenile polyposis syndrome?

Juvenile polyposis syndrome is classified as a rare disease. Epidemiological data is challenging to verify because of the phenotypic variability of the condition; some individuals may carry a mutation without developing a significant number of polyps, leading to under-reporting. While the NIH GARD suggests a prevalence of approximately 1 in 100,000, other clinical literature estimates as high as 1 in 16,000. Within the DiseaseMaps.org community, 12 individuals have currently registered with Juvenile polyposis syndrome, providing a vital, real-world perspective on the lived experience of this condition.

Are there demographic differences in Juvenile polyposis syndrome?

Research indicates that Juvenile polyposis syndrome affects males and females equally, with no significant predilection for specific ethnic groups or geographic regions. Regarding age of onset, the condition is typically diagnosed in childhood or early adulthood, though it can present at any age. Key factors influencing the diagnosis of Juvenile polyposis syndrome include:

• Clinical criteria: Diagnosis often requires more than five juvenile polyps in the colorectum, or any number of juvenile polyps in the upper gastrointestinal tract.


• Genetic markers: Approximately 20% to 50% of patients have identifiable mutations in the SMAD4 or BMPR1A genes.


• Variable penetrance: Many individuals with the genetic mutation for Juvenile polyposis syndrome may not exhibit severe symptoms early in life, causing a delay in formal diagnosis.

Why is accurate data on Juvenile polyposis syndrome limited?

The primary challenge in mapping the prevalence of Juvenile polyposis syndrome is the high rate of clinical under-diagnosis. Because symptoms like rectal bleeding or abdominal pain are common in the general population, many patients with Juvenile polyposis syndrome are not screened until a family member is diagnosed or complications arise. Consequently, the rarity of the disease makes large-scale epidemiological studies difficult to conduct, relying heavily on clinical registry data rather than population-wide screening.

Next steps

• Consult a gastroenterologist or clinical geneticist to discuss genetic testing if you have a family history of juvenile polyps.


• Join the DiseaseMaps.org community to connect with other families navigating the challenges of Juvenile polyposis syndrome.


• Establish a regular surveillance schedule (typically periodic colonoscopy and upper endoscopy) as recommended by your specialist.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of a qualified healthcare provider.

References

• Orphanet: Juvenile Polyposis Syndrome (ORPHA:732)


• NIH Genetic and Rare Diseases Information Center (GARD): Juvenile Polyposis Syndrome


• OMIM (Online Mendelian Inheritance in Man): Juvenile Polyposis Syndrome (#174900)


• PubMed/NCBI: Clinical and Genetic Characteristics of Juvenile Polyposis Syndrome